Colony Group’s PureTech Health PRTC Stock Holding History

Colony Group’s Portfolio PRTC Stock Details PRTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-262,600	Closed	-$1.45M	–	792
2021 Q1	$1.45M	Hold	262,600	–	–	0.03%	337
2020 Q4	$1.44M	Buy	+262,600	New	+$11.7M	0.03%	315

Other funds holding PRTC

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Colony Group's PRTC Position: Q2 2021 in Review

Colony Group sold out of PureTech Health (PRTC) in Q2 2021, closing a stake of 262,600 shares — an estimated $1.45M sold.

Colony Group first reported a position in PRTC in Q4 2020 and held it in 2 quarters. The position peaked at $1.45M in Q1 2021. 2 funds tracked by Wall St. Rank hold PRTC as of Q2 2021.

Colony Group reported no remaining PureTech Health position as of Q2 2021 after selling out during the quarter.
Colony Group sold 262,600 PureTech Health shares in Q2 2021, an estimated $1.45M.
Colony Group first reported a position in PureTech Health in Q4 2020 and held it in 2 quarters.
Colony Group's PureTech Health position peaked at $1.45M in Q1 2021.
2 funds tracked by Wall St. Rank held PureTech Health as of Q2 2021.

Based on Colony Group's 13F filing for Q2 2021, filed 18 Aug 2021.